N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
暂无分享,去创建一个
W. Nishio | S. Matsumoto | Y. Ohno | D. Takenaka | K. Sugimura | T. Yoshikawa | H. Koyama | Y. Maniwa | T. Itoh | M. Nishio | Y. Nishimura | N. Aoyama | Y. Onishi
[1] M. Tsuboi,et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). , 2010, Japanese journal of clinical oncology.
[2] H. Shirato,et al. Metastases in Mediastinal and Hilar Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Quantitative Assessment With Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion Coefficient , 2010, Journal of computer assisted tomography.
[3] Y. Fujibayashi,et al. The Effectiveness of 18F-FDG PET/CT Combined with STIR MRI for Diagnosing Nodal Involvement in the Thorax , 2008, Journal of Nuclear Medicine.
[4] P. Boiselle,et al. Mediastinal Lymph Nodes in Patients With Non-small Cell Lung Cancer: Preliminary Experience With Diffusion-weighted MR Imaging , 2008, Journal of thoracic imaging.
[5] S. Shiraishi,et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. , 2008, The Journal of thoracic and cardiovascular surgery.
[6] Y. Ohno,et al. STIR turbo SE MR imaging vs. coregistered FDG‐PET/CT: Quantitative and qualitative assessment of N‐stage in non‐small‐cell lung cancer patients , 2007, Journal of magnetic resonance imaging : JMRI.
[7] Michael K Gould,et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). , 2007, Chest.
[8] Michael Wallace,et al. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.
[9] D. Baldwin,et al. Lung cancer outcomes at a UK cancer unit between 1998-2001. , 2007, Lung cancer.
[10] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[11] Michael T. Halpern,et al. EVALUATION OF HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF ANEMIA AMONG CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS , 2005 .
[12] Byung-Tae Kim,et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. , 2005, Radiology.
[13] T. Araki,et al. Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.
[14] Y. Ohno,et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. , 2004, Radiology.
[15] Thomas Beyer,et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. , 2003, Radiology.
[16] Hiroto Hatabu,et al. Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. , 2002, European journal of radiology.
[17] G. Watanabe,et al. Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis; clinicopathologic features and patterns of nodal spread. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[18] John Ludbrook,et al. Statistical Techniques For Comparing Measurers And Methods Of Measurement: A Critical Review , 2002, Clinical and experimental pharmacology & physiology.
[19] Y. Doki,et al. Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple‐marker reverse transcriptase‐polymerase chain reaction assay , 2001, Cancer.
[20] S. Tsujitani,et al. Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer , 2001, Gastric Cancer.
[21] M. Okada,et al. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? , 2001, The Annals of thoracic surgery.
[22] A. Jemal,et al. Recent trends in lung cancer mortality in the United States. , 2001, Journal of the National Cancer Institute.
[23] J. Deslauriers,et al. Clinical and surgical staging of non-small cell lung cancer. , 2000, Chest.
[24] P C Goodman,et al. Staging non-small cell lung cancer with whole-body PET. , 1999, Radiology.
[25] P Grenier,et al. CT demonstration of the 1996 AJCC-UICC regional lymph node classification for lung cancer staging. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.
[26] U. Pastorino,et al. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. , 1999, The Journal of thoracic and cardiovascular surgery.
[27] E. van Marck,et al. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. , 1997, The European respiratory journal.
[28] R. Wahl,et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.